The World Market for Point of Care (POC) Diagnostics
NEW YORK, Jan. 29, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
The World Market for Point of Care (POC) Diagnostics
http://www.reportlinker.com/p01080629/The-World-Market-for-Point-of-Care-POC-Diagnostics.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic
Point-of-care (POC) tests are diagnostic tests that are performed at or near the site where the patient is located. They are performed in decentralized settings, outside of central hospital laboratories or centralized reference laboratories. Growth in POC testing is being fueled by many factors including the growing number of people with diabetes, the globalization of infectious diseases and the associated public health issues, advances in therapies giving physicians more tools for treatment of patients if the doctor is able to rapidly diagnose the problem, the need to monitor an ever-growing group of people with chronic diseases such as cardiovascular diseases, arthritis, cancer and other chronic conditions, and many other factors.
Point of Care Testing (POCT) is attracting considerable investor and industry activity. This Kalorama Information report, The World Market for Point of Care Diagnostics, the result of primary and secondary research into the point of care diagnostics market, presents the most current analysis of the POC Diagnostics industry and the role it plays in medical practice. This report takes an in depth look at the market, technologies, and trends in decentralized testing, looking at both self-testing by patients (also referred to as the over-the-counter (OTC) market, and at point-of-care testing by healthcare professionals.
As part of this report's coverage, the following data is included:
- Molecular POC Test Products and the Future of Molecular POC
- Self-Testing Point of Care Test Market by Category, Worldwide (Glucose, Infectious Diseases, Critical Care, Cardiac Markers, Hematology, Coagulation, Fecal Occult Blood, HbA1c, Cholesterol/Lipids, Drugs of Abuse, Pregnancy/Ovulation, Other)
- Professional Point of Care Testing Market by Test Category, Worldwide, 2011 and 2016 (Glucose, Pregnancy/Ovulation, Fecal occult blood, Coagulation, Drugs of abuse, Cholesterol, HIV, Other)
- Regional Breakout of POC Market (US, EU, Japan, ROW)
- Blood Glucose Monitoring Markets
- Small Footprint and POC Chemistry Systems
- Small Footprint and POC Hematology Systems
- Small Footprint and POC Immunoassay Systems
- Non-Invasive Testing Innovations
- Miniaturization and Microfluidics Innovations
- POC Test Revenues of Selected IVD Companies
- Selected Rapid HIV Tests on the Market
- Comparative Effectiveness, Healthcare Reform and Other Trends in IVD
- Hospital POCT, Physician Office POCT, Critical Care POCT
All countries are feeling the brunt of aging populations and an increased burden of chronic disease management. Employers and insurance companies are interested in improving the health of customers, and there are some innovative tactics developing in this area. The report is conservative in its predictions and offers a calculated look into the future, based on events currently taking place.
The field for rapid test devices is crowded. This report profiles 140 companies that currently market POC, plus more than 40 additional companies that are developing POC technologies and products or that have just recently entered this market. Companies profiled in this report are using a wide range of different technologies to develop and market rapid tests for much of the range of in vitro diagnostic (IVD) tests that can be performed in centralized laboratories.
The report offers a quantitative assessment of specific markets, worldwide, in U.S. dollars for 2011 to 2016. Information is provided in order to set the status quo of tests and technologies, and to get a look at what is coming. The report also discusses how these tests will affect the economics of healthcare over the near term and longer when possible.
CHAPTER ONE: EXECUTIVE SUMMARY
Size of POC Market
Trends
CHAPTER TWO: INTRODUCTION
Introduction and Definitions
Advantages and Disadvantages of Point-of-Care Testing
CHAPTER THREE: TECHNOLOGY INNOVATIONS IN POINT-OF-CARE TESTING
Miniaturization and Microfluidics Technologies
Wireless Technology
Informatics
Molecular Diagnostics
CHAPTER FOUR: LOCATIONS FOR POINT-OF-CARE TESTING
POC Testing in Hospitals and Clinics
Physicians' Office Laboratories
Retail Outlets
Other Professional POC Testing
Workplace Testing
Home Monitoring - Telemedicine
Home Self Testing
CHAPTER FIVE: POINT-OF-CARE TESTING MARKET ANALYSIS
Market Overview POC Markets – Current Markets and Market Forecasts
CHAPTER SIX: POINT-OF-CARE MARKET SEGMENTS
Diabetes Pregnancy and Ovulation
Clinical Chemistry
Urinalysis
Blood Gas
Infectious Diseases
Hematology
Coagulation
Cardiac
Drug Testing
Allergy
POC Testing Market of the Future - Molecular Diagnostics
CHAPTER SEVEN: HEALTHCARE ECONOMICS AND HEALTHCARE REFORM
Heathcare Economics and Outcomes Testing Healthcare Reform
CHAPTER EIGHT: COMPANY PROFILES – COMPANIES MARKETING POC TEST PRODUCTS
1 Step Detect Associates
3M
3test
77 Elektronika Kft.
A. Menarini Diagnostics
Abaxis, Inc.
Abbott Diagnostics
AccuBioTech Co., Ltd.
Accumetrics
Accutech
Acon Laboratories
Acrongenomics Inc.
Advanced Care Products
Advanced Microdevices Pvt. Ltd.
Aerscher Diagnostics
AgaMetrix, Inc.
Aimedics (Australia)
Akers Biomedical
Alere
Alfa Scientific Designs, Inc.
Alfa Wassermann Diagnostic Technologies, LLC
Alliance International Co., Ltd.
All Medicus
Amedica Biotech
American Bio Medica Corp
American Screening Corporation
AmeriTek
Ampcor
Analyticon Biotechnologies AG
Ani Biotech/Ani Laboratories
Apex Biotechnology Corp.
Applied Microarrays
ARJ Medical
ARKRAY, Inc.
Arlington Scientific, Inc.
Artron Laboratories
AspenBio Pharma, Inc.
Ativa Medical
Atlas Genetics
Atlas Link Biotech Co., Ltd.
Atonomics A/S
Audit Diagnostics
Autobio Diagnostics Co., Ltd.
Aventir Biotech
Axis-Shield plc
Axxin
AZOG, Inc.
B.R.A.H.M.S. AG
Bayer Diabetes Care
BD GeneOhm
Beckman Coulter Inc.
Becton, Dickinson and Company (BD)
Bestgen
BioAssay Works, LLC
Biocartis
BioHelix
Biohit HealthCare
BioLand Technology Ltd.
bioLytical Laboratories Inc.
Biomagnetics Diagnostics Corporation
Biomedix, Inc.
BioMedomics
Biomerica, Inc.
bioMerieux Inc.
Bioptik Technology, Inc
Bio-Rad Laboratories Inc.
BioScan
BioSence Medical Devices
Biosensia
BioSys Laboratories, Inc.
Biota
Biotest Medical
Blue Cross Biomedical Company
Boditech Med Inc.
BodyTel Scientific, Inc.
Boson Biotech Co., Ltd.
Branan Medical Corporation
BTNX Inc
Calypte Biomedical Corporation
Cambridge Sensors Ltd. and/or Cambridge Sensors USA
Cepheid
CERAGEM Medisys Inc.
Chematics
Chembio Diagnostic Systems, Inc.
Clarity Diagnostics
Clinical Innovations, LLC
Concateno plc
ContraVac, Inc.
CTK Biotech Inc.
DENKA SEIKEN CO., LTD.
DexCom, Inc.
DFI Co., Ltd.
Diabetech, LP
Diabetes Sentry Products Inc.
Diaglobal GmbH
Diagnostics for All (DFA)
Diagnostics for the Real World (DRW)
DiaSys Diagnostic Systems
Diazyme Laboratories
DxNA
Echo Therapeutics, Inc.
EKF-diagnostic Gmb
Elitech Group
Enigma Diagnostics Limited
Entra Health Systems
Epinex Diagnostics Laboratories, Inc.
Epocal, Inc.
EUMED Biotechnology Co. Ltd.
Fora Care
GenBio
GeneFluidics
General Biologicals Corp.
GenPrime, Inc.
GluMetrics
Heidelberger-Medical-Marketing GmbH (HMM GmbH)
Helena Laboratories USA
Hema Diagnostic Systems
HemoCue, Inc. A Quest Diagnostic Company
Hemosure
Horiba ABX S.A.
Identa Corporation
iLine Microsystems
inBios International Inc.
Innovative Biosensors, Inc.
Instrumentation Laboratory
Integrity Applications Ltd.
International Technidyne Corp (ITC)
Inverness Medical Innovations
Investigen
Ionian Technologies
IQuum, Inc.
Jant Pharmacal
LifeAssays AB
Lifescan Inc.
LifeSign LLC
Liming Bio-products Co., Ltd.
Magellan Diagnostics
Magnisense
Masimo Corporation
mBio Diagnostics
MedMira Inc.
Medtronic Inc.
Meridian Bioscience
Metaara Medical Technologies Inc
microfluidic ChipShop GmbH
Micronics Inc.
Micropoint Bioscience, Inc.
Miraculins
MP Biomedicals LLC
MycroLab Pty Ltd.
Nanomix, Inc.
Nanosphere, Inc.
Network Biosystems, Inc. (NetBio)
Nexus Dx, Inc. (Subsidiary of Samsung Electronics Co.)
Nipro Diagnostics
Noninvasive Medical Technologies, Inc.
Nova Biomedical
OPKU Health
OPTI Medical Systems, Inc.
OraSure Technologies, Inc.
Orion Diagnostica
OrSense Ltd.
Ortho Clinical Diagnostics
Oxonica Diagnostics
Pepex Biomedical
pes diagnosesysteme GmbH
PlaCor, Inc.
PointCare Technologies
Polymedco, Inc.
Polymer Technology Systems, Inc.
Princeton Biomeditech Corp
Probe Scientific Ltd
Prodigy Diabetes Care
Propper Manufacturing Co.
Qiagen N.V.
QuantuMDx Group
Quidel Corporation
QuikTest USA, Inc.
Quotient Diagnostics
Radiometer A/S
Rapid Pathogen Screening
ReLIA Diagnostic Systems
Rennesens GmbH
Response Biomedical Corp.
Rheonix, Inc.
Roche Diagnostics
SAKAE Corporation
Savyon Diagnostics
Sekisui Diagnostics
Siemens Healthcare Diagnostics
Sysmex Corporation
Thermo Scientific
Zonda, Inc.
Selected Tables
POC Sales by Test Category, Worldwide
World Glucose Monitoring Sales by Company
Selected Continuous Blood Glucose Monitoring Systems
Selected OTC Pregnancy and Ovulation Tests
Selected POC Clinical Chemistry Systems
Selected Urinalysis POC Tests
Selected POC Blood Gas Systems
Selected Rapid Infectious Disease Tests
Selected POC Coagulation Tests
Selected Molecular Diagnostic Companies Targeting Rapid or POC Market
To order this report:
: The World Market for Point of Care (POC) Diagnostics
Contact Nicolas: [email protected]
US: (805)-652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article